Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Trevi Therapeutics, Inc. See All Filings	D	2022-04-18 16:57:17 UTC
Amount To Be Raised $54,999,998 Associated Brokers / Dealers Stifel, Nicolaus & Company, Incorporated, Needham & Company, LLC, Oppenheimer & Co. Inc., and Aegis Capital Corp. CIK Number 0001563880 Filed Document 0001563880-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-04-18 16:57:17 UTC Type of Offering D Industry Biotechnology Principal Place of Business CONNECTICUT Revenue or Assets Decline to Disclose Type of Security Equity
Trevi Therapeutics, Inc. See All Filings	D	2021-10-21 16:25:29 UTC
Amount To Be Raised $3,000,000 Associated Brokers / Dealers N/A CIK Number 0001563880 Filed Document 0001563880-21-000003 Exclusions or Exemptions 506b Accepted Date 2021-10-21 16:25:29 UTC Type of Offering D Industry Biotechnology Principal Place of Business CONNECTICUT Revenue or Assets Decline to Disclose Type of Security Equity
Trevi Therapeutics, Inc. See All Filings	D	2021-10-20 16:10:41 UTC
Amount To Be Raised $11,819,891 Associated Brokers / Dealers Stifel, Nicolaus & Company, Incorporated and Needham & Company, LLC CIK Number 0001563880 Filed Document 0001563880-21-000001 Exclusions or Exemptions 506b Accepted Date 2021-10-20 16:10:41 UTC Type of Offering D Industry Biotechnology Principal Place of Business CONNECTICUT Revenue or Assets Decline to Disclose Type of Security Equity
Trevi Therapeutics, Inc. See All Filings	D/A	2018-09-05 16:43:12 UTC
Amount To Be Raised $61,906,460 Associated Brokers / Dealers N/A CIK Number 0001563880 Filed Document 0001563880-18-000002 Exclusions or Exemptions 506b Accepted Date 2018-09-05 16:43:12 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business CONNECTICUT Revenue or Assets Decline to Disclose Type of Security Equity
Trevi Therapeutics, Inc. See All Filings	D	2017-07-24 16:24:52 UTC
Amount To Be Raised $66,656,460 Associated Brokers / Dealers N/A CIK Number 0001563880 Filed Document 0001563880-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-07-24 16:24:52 UTC Type of Offering D Industry Biotechnology Principal Place of Business CONNECTICUT Revenue or Assets Decline to Disclose Type of Security Equity